ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
Quick Stats
Jan 30, 202654.8
AI Score
HOLD1.12
Volume Ratio
Mar 12, 2026
Next Earnings
13
+ve Days (30d)
16
-ve Days (30d)
ADCT Stock Summary
Last updated Jan 30, 2026
ADCT is currently trading at $3.61, positioned above its 200-day moving average of $3.26, indicating a long-term uptrend. The stock has a 52-week range of $1.05 to $4.8.
Technical Analysis: The 50-day moving average stands at $3.76, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 48.27, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.122, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ADCT at 54.8/100 with a HOLD recommendation.
ADCT (ADC Therapeutics SA) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.27 |
| CMF (20) | 0.122 |
| ROC (10) | 1.69 |
| ADX (14) | 9.55 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.028 |
| AROONOSC (14) | -78.571 |
| WILLAMS %R (14) | -43.75 |
| MFI (14) | 29.962 |
ADCT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ADCT Price vs Max Options Open Interest
ADCT Max Change In Options Open Interest
ADCT Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADCT Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADCT Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADCT Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADC Therapeutics SA is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ADCT Moving Averages Analysis
ADC Therapeutics SA has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
ADCT (ADC Therapeutics SA) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 3.63 |
| 20 | 3.63 |
| 30 | 3.62 |
| 50 | 3.76 |
| 100 | 3.87 |
| 200 | 3.26 |
ADCT Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 447.2 million |
| Earnings/Share ($) | -1.35 |
| Net Proft Margin (%) | -2.2197 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.3917 |
| EPS Estimate Next Year ($) | -1.075 |
| WallStreet Target Price ($) | 8 |
| Most Recent Quarter |